Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic Kidney Disease (PKD) Awareness Day, an initiative that aims to increase ...

SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation of genetic medicines, today announced it will officially launch a $125M ...

Minimally invasive surgery linked to lower major complication risk, reduced length of stay, decreased transfusion rate.

Data from this Australian study showed a higher prevalence of intracranial aneurysms (ICAs) in patients with ADPKD compared with the general population. Many patients in the study had no known risk ...

U.S.-based researchers examined the burden of imaging in a population of patients with ADPKD, versus that of patients with chronic kidney disease (CKD). People with ADPKD underwent more abdominal ...

Dapagliflozin improved eGFR slope in patients with CKD associated with ADPKD, but it resulted in an increase in kidney volume. Dapagliflozin may exert a protective effect on kidney function in ...

Please provide your email address to receive an email when new articles are posted on . Patients with autosomal dominant polycystic kidney disease have a preferable cardiac profile before ...

Initial change in eGFR after tolvaptan administration independently predicted the annual rate of eGFR decline in patients with ADPKD. Initial declines in estimated glomerular filtration rate (eGFR) ...

F inding out you have autosomal dominant polycystic kidney disease (ADPKD) can be a life-altering event, even if you haven’t yet experienced any symptoms. One of the most common genetic diseases, ...

Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney disease (ADPKD), according to a study published online Dec. 17 in Urology ...

Minimally invasive surgery linked to lower major complication risk, reduced length of stay, decreased transfusion rate.